{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:59:03Z","timestamp":1790704743129,"version":"4.1.0"},"reference-count":27,"publisher":"IMR Press","issue":"9","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br. J. Hosp. Med. (Lond)"],"abstract":"<jats:p>Aims\/Background: Suboptimal glycaemic control may delay surgery and increase perioperative risk, yet national guidance provides limited detail on how preoperative diabetes optimisation should be organised. This study evaluated a multidisciplinary perioperative diabetes optimisation pathway in a tertiary hospital. Methods: This prospective single-centre cohort included 174 consecutive adults referred to The Queen Elizabeth Hospital Birmingham, United Kingdom, between 1 January and 31 December 2024, with glycated haemoglobin (HbA1c) &gt;69 mmol\/mol (&gt;8.5%) before elective surgery. The pathway comprised diabetologist assessment, individualised treatment adjustment, diabetes specialist nurse follow-up, education, repeat HbA1c measurement and communication with surgical teams. Primary outcomes were change in HbA1c and achievement of HbA1c \u226469 mmol\/mol (\u22648.5%). Secondary outcomes included progression to surgery and factors associated with target achievement and follow-up HbA1c. Multivariable logistic and linear regression examined target achievement and follow-up HbA1c, respectively. Results: Paired data were available for 149\/174 patients (85.6%). Mean HbA1c decreased from 96.2 \u00b1 14.0 to 73.1 \u00b1 14.1 mmol\/mol, a reduction of 23.1 mmol\/mol (2.1 percentage points; p &lt; 0.001); 77\/149 patients (51.7%) achieved the target. Higher baseline HbA1c was associated with lower odds of target achievement (odds ratio 0.96 per mmol\/mol, 95% confidence interval 0.94\u20130.99; p = 0.006), although patients with the highest baseline values achieved the largest absolute reductions. After adjustment for baseline HbA1c and other covariates, each additional diabetes-team appointment was associated with a 0.58 mmol\/mol lower follow-up HbA1c (95% confidence interval \u22120.98 to \u22120.18; p = 0.005). Overall, 124\/174 patients (71.3%) proceeded to surgery. Conclusion: Referral to the pathway was associated with substantial improvement in preoperative HbA1c; just over half of patients achieved the preoperative target and most proceeded to surgery. Baseline HbA1c identified patients less likely to reach the fixed target despite larger absolute reductions, while more frequent specialist contact was modestly associated with lower follow-up HbA1c. Coordinated specialist follow-up, including pragmatic basal insulin initiation and titration where clinically indicated, provides a reproducible hospital-based model for preoperative diabetes optimisation.<\/jats:p>","DOI":"10.31083\/bjhm55387","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:59:52Z","timestamp":1790701192000},"source":"Crossref","is-referenced-by-count":0,"title":["A Multidisciplinary Perioperative Diabetes Optimisation Pathway: Glycaemic and Hospital Pathway Outcomes in a Prospective Cohort"],"prefix":"10.31083","volume":"87","author":[{"given":"Kavitha Dhevi","family":"Krishnasamy Ganapathy","sequence":"first","affiliation":[{"name":"Department of Diabetes and Endocrinology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, B15 2TH Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiul","family":"Mostafa","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, B15 2TH Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brighid","family":"Lane","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, B15 2TH Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Kurian","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, B15 2TH Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0691-8993","authenticated-orcid":true,"given":"Feaz","family":"Babwah","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, B15 2TH Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"ref1","unstructured":"NHS Digital. National Diabetes Inpatient Audit (NaDIA) \u2013 2019. 2020. Available at: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/national-diabetes-inpatient-audit\/2019 (Accessed: 21 May 2026)."},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Membership of the Working Party, Barker P, Creasey PE, Dhatariya K, Levy N, Lipp A, et al. Peri-operative management of the surgical patient with diabetes 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia. 2015; 70: 1427\u20131440.","DOI":"10.1111\/anae.13233"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Polderman JAW, Hermanides J, Hulst AH. Update on the perioperative management of diabetes mellitus. BJA Education. 2024; 24: 261\u2013269.","DOI":"10.1016\/j.bjae.2024.04.007"},{"key":"ref4","unstructured":"International Diabetes Federation. IDF Diabetes Atlas 2025. 2025. Available at: https:\/\/diabetesatlas.org\/resources\/idf-diabetes-atlas-2025\/ (Accessed: 28 June 2026)."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Shanks AM, Woodrum DT, Kumar SS, Campbell DA Jr, Kheterpal S. Intraoperative hyperglycemia is independently associated with infectious complications after non-cardiac surgery. BMC Anesthesiology. 2018; 18: 90.","DOI":"10.1186\/s12871-018-0546-0"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Kwon S, Thompson R, Dellinger P, Yanez D, Farrohki E, Flum D. Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program. Annals of Surgery. 2013; 257: 8\u201314.","DOI":"10.1097\/SLA.0b013e31827b6bbc"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Duncan AE, Abd-Elsayed A, Maheshwari A, Xu M, Soltesz E, Koch CG. Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery. Anesthesiology. 2010; 112: 860\u2013871.","DOI":"10.1097\/ALN.0b013e3181d3d4b4"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Zhang X, Hou A, Cao J, Liu Y, Lou J, Li H, et al. Association of Diabetes Mellitus With Postoperative Complications and Mortality After Non-Cardiac Surgery: A Meta-Analysis and Systematic Review. Frontiers in Endocrinology. 2022; 13: 841256.","DOI":"10.3389\/fendo.2022.841256"},{"key":"ref9","unstructured":"Centre for Perioperative Care. Guideline for perioperative care for people with diabetes mellitus undergoing elective and emergency surgery. 2021. Available at: https:\/\/cpoc.org.uk\/sites\/cpoc\/files\/documents\/2021-05\/CPOC-Diabetes-Guideline2021.pdf (Accessed: 6 June 2026)."},{"key":"ref10","unstructured":"Joint British Diabetes Societies for Inpatient Care. Management of adults with diabetes undergoing surgery and elective procedures: improving standards. 2023. Available at: https:\/\/abcd.care\/resource\/current\/jbds-03-management-adults-diabetes-undergoing-surgery-and-elective-procedures (Accessed: 29 May 2026)."},{"key":"ref11","unstructured":"National Institute for Health and Care Excellence. Perioperative care in adults. 2020. Available at: https:\/\/www.nice.org.uk\/guidance\/ng180 (Accessed: 29 May 2026)."},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes*. 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2026. Diabetes Care. 2026; 49: S339\u2013S355.","DOI":"10.2337\/dc26-S016"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Thompson A, Fleischmann KE, Smilowitz NR, de Las Fuentes L, Mukherjee D, Aggarwal NR, et al. 2024 AHA\/ACC\/ACS\/ASNC\/HRS\/SCA\/SCCT\/SCMR\/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024; 150: e351\u2013e442.","DOI":"10.1161\/CIR.0000000000001285"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Ushakumari DS, Sladen RN. ASA Consensus-based Guidance on Preoperative Management of Patients on Glucagon-like Peptide-1 Receptor Agonists. Anesthesiology. 2024; 140: 346\u2013348.","DOI":"10.1097\/ALN.0000000000004776"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Kindel TL, Wang AY, Wadhwa A, Schulman AR, Sharaiha RZ, Kroh M, et al. Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Surgical Endoscopy. 2025; 39: 180\u2013183.","DOI":"10.1007\/s00464-024-11263-2"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"El-Boghdadly K, Dhesi J, Fabb P, Levy N, Lobo DN, McKechnie A, et al. Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association. Anaesthesia. 2025; 80: 412\u2013424.","DOI":"10.1111\/anae.16541"},{"key":"ref17","unstructured":"National Confidential Enquiry into Patient Outcome and Death. Highs and Lows: a review of the quality of care provided to patients over the age of 16 who had diabetes and underwent a surgical procedure. 2018. Available at: https:\/\/www.ncepod.org.uk\/2018pd\/Highs%20and%20Lows_Full%20Report.pdf (Accessed: 6 June 2026)."},{"key":"ref18","unstructured":"Rayman G, Kar P. Diabetes: GIRFT Programme National Specialty Report. 2020. Available at: https:\/\/gettingitrightfirsttime.co.uk\/wp-content\/uploads\/2022\/01\/GIRFT-diabetes-report.pdf (Accessed: 20 June 2026)."},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Mendez CE, Wainaina N, Walker RJ, Montagne W, Livingston A, Slawski B, et al. Preoperative Diabetes Optimization Program. Clinical Diabetes : a Publication of the American Diabetes Association. 2018; 36: 68\u201371.","DOI":"10.2337\/cd17-0088"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Hommel I, Wollersheim H, Tack CJ, Mulder J, van Gurp PJ, Hulscher MEJL. Impact of a multifaceted strategy to improve perioperative diabetes care. Diabetic Medicine : a Journal of the British Diabetic Association. 2017; 34: 278\u2013285.","DOI":"10.1111\/dme.13130"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Rayman G, Page E, Hodgson S, Henley W, Wr Briggs T, Gray WK. Improving the outcomes for people with diabetes undergoing surgery: An observational study of the Improving the Peri-operative Pathway of People with Diabetes (IP3D) intervention. Diabetes Research and Clinical Practice. 2024; 207: 111062.","DOI":"10.1016\/j.diabres.2023.111062"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Ruzycki SM, Kuzma T, Harrison TG, McKeen J, Helmle K, Beesoon S, et al. Implementation of a Perioperative Glycemic Management Quality Improvement Pathway in Gynecologic Oncology Patients: A Single-cohort Interrupted Time-series Analysis. Canadian Journal of Diabetes. 2023; 47: 228\u2013235.e5.","DOI":"10.1016\/j.jcjd.2022.11.007"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Yu A, Truong Q, Whitfield K, Hale A, Taing MW, Barker N, et al. Impact of preoperative haemoglobin A1c levels on postoperative outcomes in adults undergoing major noncardiac surgery: A systematic review. Diabetic Medicine : a Journal of the British Diabetic Association. 2024; 41: e15380.","DOI":"10.1111\/dme.15380"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Wong JKL, Ke Y, Ong YJ, Li H, Wong TH, Abdullah HR. The impact of preoperative glycated hemoglobin (HbA1c) on postoperative complications after elective major abdominal surgery: a meta-analysis. Korean Journal of Anesthesiology. 2022; 75: 47\u201360.","DOI":"10.4097\/kja.21295"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Underwood P, Askari R, Hurwitz S, Chamarthi B, Garg R. Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care. 2014; 37: 611\u2013616.","DOI":"10.2337\/dc13-1929"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Kim S, Park J, Kim H, Yang K, Choi JH, Kim K, et al. Intraoperative Hyperglycemia May Be Associated with an Increased Risk of Myocardial Injury after Non-Cardiac Surgery in Diabetic Patients. Journal of Clinical Medicine. 2021; 10: 5219.","DOI":"10.3390\/jcm10225219"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Putzu A, Grange E, Schorer R, Schiffer E, Gariani K. Continuous peri-operative glucose monitoring in noncardiac surgery: A systematic review. European Journal of Anaesthesiology. 2025; 42: 162\u2013171.","DOI":"10.1097\/EJA.0000000000002095"}],"container-title":["British Journal of Hospital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/9\/10.31083\/BJHM55387","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:00:25Z","timestamp":1790701225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/9\/10.31083\/BJHM55387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1759-7390(26)04745-0"],"URL":"https:\/\/doi.org\/10.31083\/bjhm55387","relation":{},"ISSN":["1750-8460","1759-7390"],"issn-type":[{"value":"1750-8460","type":"print"},{"value":"1759-7390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"article-number":"55387"}}